Search - tctmd.com

Displaying 341 - 360 of 513

Sort: Relevancy | Date

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

October 24, 2012

News Conference News TCT 2012

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

October 24, 2012

News Industry News

The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions

October 23, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

News Industry News

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

October 23, 2012

News Conference News TCT 2012

Large Study Finds Comparable 8-Month TVF for PES, SES

October 23, 2012

News Conference News TCT 2012

Several Trials Highlight DES Comparisons

October 22, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 22, 2012

News Conference News TCT 2012

New Results from SYNTAX, SPIRIT Trials Presented

October 22, 2012

News Conference News TCT 2012

Meta-Analyses Show Improved Outcomes with DES vs. BMS

October 22, 2012

News Industry News

Medtronic Completes Enrollment in Landmark Study of IN.PACT Drug-Eluting Balloon in Peripheral Artery Disease

October 05, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Industry News

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

September 25, 2012

News Industry News

Eurocor’s DEBIFU Registry successfully enrolled first patients

September 24, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

L.A. McKeown

September 10, 2012

Advertisement

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

Large Study Finds Comparable 8-Month TVF for PES, SES

Several Trials Highlight DES Comparisons

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

New Results from SYNTAX, SPIRIT Trials Presented

Meta-Analyses Show Improved Outcomes with DES vs. BMS

Medtronic Completes Enrollment in Landmark Study of IN.PACT Drug-Eluting Balloon in Peripheral Artery Disease

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Stent Fractures Persist Among Newer-Generation Devices

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

Eurocor’s DEBIFU Registry successfully enrolled first patients

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content